NOT FOR DISTRIBUTION
Header cover image

Market Cap

Rp6.9t

Last Updated

2021/05/09 17:07 UTC

Data Sources

Company Financials

Executive Summary

PT Tempo Scan Pacific Tbk engages in the pharmaceuticals, personal care and cosmetics, and distribution services businesses in Indonesia and internationally. More Details


Snowflake Analysis

Undervalued with solid track record.


Similar Companies

Share Price & News

How has Tempo Scan Pacific's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: TSPC is less volatile than 75% of ID stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: TSPC's weekly volatility (3%) has been stable over the past year.


Market Performance


7 Day Return

0.7%

TSPC

1.3%

ID Pharmaceuticals

-0.5%

ID Market


1 Year Return

27.5%

TSPC

20.4%

ID Pharmaceuticals

22.3%

ID Market

Return vs Industry: TSPC exceeded the ID Pharmaceuticals industry which returned 19.3% over the past year.

Return vs Market: TSPC exceeded the ID Market which returned 23.4% over the past year.


Shareholder returns

TSPCIndustryMarket
7 Day0.7%1.3%-0.5%
30 Day-4.7%-3.8%-2.7%
90 Day1.7%-9.1%-5.5%
1 Year32.2%27.5%22.7%20.4%26.3%22.3%
3 Year5.9%-2.9%2.3%-3.3%2.3%-5.4%
5 Year-10.4%-22.1%32.9%20.3%34.1%17.8%

Long-Term Price Volatility Vs. Market

How volatile is Tempo Scan Pacific's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Tempo Scan Pacific undervalued compared to its fair value and its price relative to the market?

49.6%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: TSPC (IDR1530) is trading below our estimate of fair value (IDR3033.49)

Significantly Below Fair Value: TSPC is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: TSPC is good value based on its PE Ratio (8.7x) compared to the ID Pharmaceuticals industry average (25x).

PE vs Market: TSPC is good value based on its PE Ratio (8.7x) compared to the ID market (22.3x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate TSPC's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: TSPC is good value based on its PB Ratio (1.1x) compared to the ID Pharmaceuticals industry average (2.4x).


Future Growth

How is Tempo Scan Pacific forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

18.4%

Forecasted Pharmaceuticals & Biotech industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Tempo Scan Pacific has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Tempo Scan Pacific performed over the past 5 years?

5.4%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: TSPC has high quality earnings.

Growing Profit Margin: TSPC's current net profit margins (7.2%) are higher than last year (5%).


Past Earnings Growth Analysis

Earnings Trend: TSPC's earnings have grown by 5.4% per year over the past 5 years.

Accelerating Growth: TSPC's earnings growth over the past year (41.9%) exceeds its 5-year average (5.4% per year).

Earnings vs Industry: TSPC earnings growth over the past year (41.9%) exceeded the Pharmaceuticals industry 9%.


Return on Equity

High ROE: TSPC's Return on Equity (13.1%) is considered low.


Financial Health

How is Tempo Scan Pacific's financial position?


Financial Position Analysis

Short Term Liabilities: TSPC's short term assets (IDR5,941.1B) exceed its short term liabilities (IDR2,008.0B).

Long Term Liabilities: TSPC's short term assets (IDR5,941.1B) exceed its long term liabilities (IDR719.4B).


Debt to Equity History and Analysis

Debt Level: TSPC's debt to equity ratio (10.3%) is considered satisfactory.

Reducing Debt: TSPC's debt to equity ratio has increased from 2% to 10.3% over the past 5 years.

Debt Coverage: TSPC's debt is well covered by operating cash flow (149.1%).

Interest Coverage: TSPC earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is Tempo Scan Pacific current dividend yield, its reliability and sustainability?

3.27%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: TSPC's dividend (3.27%) is higher than the bottom 25% of dividend payers in the ID market (1.14%).

High Dividend: TSPC's dividend (3.27%) is low compared to the top 25% of dividend payers in the ID market (4.92%).


Stability and Growth of Payments

Stable Dividend: TSPC's dividend payments have been volatile in the past 10 years.

Growing Dividend: TSPC's dividend payments have fallen over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (28.6%), TSPC's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.3yrs

Average board tenure


CEO

Diana Wirawan (64 yo)

1.33yrs

Tenure

Ms. Diana Wirawan serves as President Director PT Tempo Scan Pacific TBK since 2020. Ms. Wirawan had been Vice President Director of PT Tempo Scan Pacific TBK from 2012 until 2020 and has been its Director...


Board Members

Experienced Board: TSPC's board of directors are considered experienced (4.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

PT Tempo Scan Pacific Tbk's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: PT Tempo Scan Pacific Tbk
  • Ticker: TSPC
  • Exchange: IDX
  • Founded: 1970
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: Rp6.885t
  • Shares outstanding: 4.50b
  • Website: https://www.thetempogroup.net

Number of Employees


Location

  • PT Tempo Scan Pacific Tbk
  • Tempo Scan Tower
  • 16th Floor
  • Jakarta
  • Jakarta Raya
  • 12950
  • Indonesia

Listings


Biography

PT Tempo Scan Pacific Tbk engages in the pharmaceuticals, personal care and cosmetics, and distribution services businesses in Indonesia and internationally. It operates through three segments: Pharmaceuti...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/05/09 17:07
End of Day Share Price2021/05/07 00:00
Earnings2020/12/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.